L’Université d’Etat de chimie et de pharmacie de Saint-Pétersbourg

07/08/2026

01/08/2026

Dear members of our community!
On July 10, 2026, nine full-time master's degree students from the Department of Economics and Management, who completed their master's degree program in "Organization and Management of Pharmaceutical Production," defended their final qualifying theses at the St. Petersburg State Chemical-Pharmaceutical University. The students' theses addressed current organizational and managerial challenges facing the domestic pharmaceutical industry, including developing export potential, conducting marketing analysis of various market segments and assessing the prospects for domestic manufacturers to enter them, analyzing the level and dynamics of drug prices at the regional level, and improving personnel management in pharmaceutical production. Most of the theses were defended at a very high level, and the students were asked numerous questions by members of the state examination committee, which included representatives of the pharmaceutical companies Biocad, Active Component, Pharmproekt, and the St. Petersburg Research Institute of Vaccines and Serums. The students answered most of the questions fully, competently, and professionally, demonstrating a high level of preparation, a thorough mastery of theoretical material, and practical skills in solving current problems in the field of organizing and managing pharmaceutical production. It is especially noteworthy that six graduates received their diplomas with honors! I wish our master's students continued professional success, successful development, reaching new heights, career advancement, and interesting work for the benefit of the Russian pharmaceutical industry! 🏅🎖🏆
From Alexander Orlov

30/07/2026

📦 Logistics in Medicine: Guaranteeing Drug Safety! 💊

How can you ensure a vaccine remains effective and a sterile bandage remains sterile? Who is responsible for ensuring that this vital drug is available even in remote areas?

In this mini-lecture, Elizaveta Eduardovna Pimonova, a lecturer in the Department of Medical and Pharmaceutical Commodity Science at St. Petersburg Chemical and Pharmaceutical University, examines the full cycle of product distribution in medicine and pharmaceuticals – from production and customs control to warehouses and pharmacies.

After watching the video, you will learn:
- What are GMP and GDP standards
- Why cold chains are necessary
- How the "Honest Sign" label works
- Why logistics in medicine is more than just transporting boxes, but a matter of national security and the health of millions

This is an area where every detail matters, and your decision can directly impact the accessibility and quality of medical care.

🎓 Do you want to manage such processes and be responsible for the quality of supplies? SPHFU offers programs that provide professional training in this area:

✅ 33.05.01 Pharmacy (Specialist) - You will understand the entire supply chain from the drug substance to the patient, including quality control, regulatory frameworks, and the specifics of drug storage and transportation. Graduates work in pharmacies, pharmaceutical factories, regulatory agencies, and the logistics departments of pharmaceutical companies.

✅ 38.03.07 Commodity Science (Bachelor's) - A program at the intersection of economics and medicine. You will learn to analyze the medical and pharmaceutical product market, understand regulatory frameworks, assess quality, and plan procurement. This is a path to leadership positions in public procurement, product management, and market analytics. ✅ 38.04.02 Management, "Organizational Supply Management" (Master's Degree) is a unique program at SPHFU, unparalleled in Russia. It doesn't just teach inventory control: it focuses specifically on supplying medical institutions—hospitals, wholesale pharmaceutical companies, and medical device suppliers. You'll master procurement regulations, supplier selection, product quality control, and supply chain optimization. Your thesis topic is tailored to your professional experience and interests—a real tool for career advancement.

Graduates of these programs are able to see not only numbers and graphs but also real risks: where supply chain disruptions can occur, how to prevent them, and how to build a system that guarantees the safety and availability of medications. This is why they are in demand in pharmaceutical companies, logistics operators, government procurement, and regulatory agencies.

⏰ Important dates for the 2026 admissions campaign:

🔹 July 25 (5:00 PM) - application deadline for state-funded places (Bachelor's and Specialist's degrees)
🔹 August 17 (5:00 PM) - application deadline for fee-paying places (Bachelor's and Specialist's degrees)
🔹 August 10 - application deadline for Master's programs (state-funded and fee-paying places).

👉 Learn more about the programs: sites.google.com/spcpu.ru/b...

Preparing for admission?

Visit the SPCPU Admissions Committee website at abiturient.pharminnotech.com

Or ask us a question:

💬 VKontakte Group: vk.ru/spcpu_admission
📞 Phone: 8 (812) 499-39-20
Mon-Fri: 10:00-17:00 | Sat: 10:00-15:00
🌐 Email: [email protected]
📍 In-person address: St. Petersburg, ul. Professor Popov, Building 14, Lit. A
Mon-Fri: 10:00-14:00 | Sat: 10:00-15:00

24/07/2026

🧪 Operator: Master a sought-after profession in just 1 year and 10 months at the Pharmaceutical College of St. Petersburg Chemical Federal University!

Have you ever wondered how a complex chemical process is controlled in production? Who ensures that the temperature, pressure, and component flow are strictly within specifications? 🤔

That's the job of an operator—a specialist who determines the stability of production and product quality.

At the Pharmaceutical College of St. Petersburg Chemical Federal University, you'll learn:

✅ Manage the technological process and understand instrument readings
✅ Assess the state of the process and promptly detect deviations
✅ Adjust parameters (temperature, pressure, dosage) and maintain the process within specified limits
✅ Monitor the health of equipment and perform basic maintenance.

Our training emphasizes not only theory but also real-world production scenarios. Students complete practical training as early as their first year! 🔥

Study: Full-time
Duration: 1 year 10 months (based on 11 grades)

👉 Learn more about admission and training: spbfarmt.pharminnotech.com/Abiturient...

Still have questions? Below are the contact details of the SPCFU Admissions Committee:

💬 VKontakte Group: vk.ru/spcpu_admission
📞 Phone: 8 (812) 499-39-20
Mon-Fri: 10:00-17:00 | Sat: 10:00-15:00
🌐 Email: [email protected]
📍 Address for in-person attendance: St. Petersburg, ul. Professor Popov, Bldg. 14, lit. A
Mon-Fri: 10:00-14:00 | Sat: 10:00-15:00

24/07/2026

🤔 Why can the same drug from different manufacturers work differently? SPHFU graduates know the answer! 🤓☝️

This requires knowledge at the intersection of chemistry, biology, engineering, and medicine.

In this video, Yulia Trukhanova, PhD, and SPHFU graduate, explains: even if drugs contain the same active ingredient, their effectiveness can vary greatly. It's all about the nuances: excipients, bioavailability, substance purity, manufacturing processes, and individual body reactions.

It's these nuances that become the main focus of our students' study. At SPHFU, you'll learn not just to memorize formulas, but to understand how a molecule is transformed into a working drug—and how to ensure its quality at every stage.

🎓 Want to understand this professionally? Choose the program that's right for you:

✅ May 33, 2001 Pharmacy - You'll become a pharmacist with a deep understanding not only of drug action but also of the specifics of their production, quality control, and application. Graduates work in pharmacies, pharmaceutical factories, and regulatory agencies.

✅ March 18, 2001 Chemical Technology - You'll learn how to synthesize a substance, select a production technology, and scale up a laboratory development to industrial production. SPHFU has its own GMP training center for this purpose, where students learn on equipment that closely resembles actual production.

✅ March 4, 2001 Chemistry - The foundation for those who want to thoroughly understand the properties of substances, methods of their analysis, and identification. This is the path to science, analytical laboratories, and the R&D departments of pharmaceutical companies.
✅ 06.03.01 Biology - for those who approach the problem from a different perspective: how the body responds to a drug, how biological targets work, and how to test new molecules in living systems.

And if you want to delve even deeper, in the SPHFU Master's program, you can choose a narrow specialization and focus on the most promising area, for example:

☑️ 04.04.01 Chemistry, "Medicinal Chemistry and Molecular Design" track. This track teaches you how to design new compounds, predict their properties, and optimize their structure for a specific biological target.

☑️ 06.04.01 Biology, "Organization and Conduct of Preclinical Studies" track. You will master GLP standards, learn how to plan experiments on model systems, and assess the safety of drugs before human trials.
☑️ April 18, 2001 Chemical Technology, specialization: "Development and Production of Medicines, Dietary Supplements, and Cosmetics." This program focuses on translating ideas into products: from formula selection to process validation and quality control in production.

SPPHU graduates are able to see the entire chain—from molecule to patient—and that's why they're in demand at leading pharmaceutical companies and research centers!

⏰ We remind you that the application deadline for higher education programs at SPCFU is:
* July 25 (5:00 PM) - for undergraduate and specialist degrees (budget-funded)
* August 17 (5:00 PM) - for undergraduate and specialist degrees (fee-funded)
* August 10, 2026 - for master's degrees (fee-funded and state-funded)

👉 Learn more about the programs: sites.google.com/spcpu.ru/b...
👉 Ask a question about admission: SPCFU Admissions Committee

This video was produced as part of High-Tech and Technopreneurship Week 2025 🧡

24/07/2026

🧡 Getting to Know SPHFU: The Academic and Laboratory Building at 6 Aptekarsky Street

Dear applicants and parents! We continue our series of walks around SPHFU's buildings – so you'll feel right at home by the time your studies begin! 😊

Today, we'll look at a familiar building from a different perspective: it's the same historic building you saw from 4 Professor Popov Street, and now its façade along Aptekarsky Avenue.

📍 Address: 6 Aptekarsky Avenue.
The nearest metro station is Petrogradskaya (800 m, 10-15 min walk).

What's located here?

- Classrooms and laboratories for the departments of the Faculty of Pharmaceutics and the Faculty of Industrial Technology of Medicines: here, students master the core disciplines of their fields.
- A student cafeteria: so they can quietly grab a snack between classes and discuss lab work with classmates.

Classes are held here for undergraduate and specialist students, as well as those continuing their studies in master's programs.

You can see what the building looks like in the video. It was produced in collaboration with the education service "University Guide" 🤝

And if you want to see where else SPHFU students study, here are links to previous episodes:

✅ Academic and administrative building at 14 Professor Popov Street: vk.com/wall-44203088_11065
✅ Academic and laboratory building at 14 Professor Popov Street: vk.com/wall-44203088_11065 Professor Popov, 4: vk.com/wall-44203088_11155
✅ Research and Laboratory Building at Kazanskaya, 12: vk.ru/wall-44203088_11179

22/07/2026

Experts have determined why foreign pharmaceutical companies maintain their market share. The share of foreign drugs in the Russian pharmaceutical market continues to decline for the seventh consecutive year. By the end of 2025, it stood at 54.1% in monetary terms—down 2.1 percentage points from the previous year. In physical terms, the decline was even more significant: imported products accounted for only 35.4% of packages. However, in value terms, foreign manufacturers continue to outperform domestic ones. This is due to their dominance in the innovative, high-cost therapy segment, according to a report by the St. Petersburg Chemical and Pharmaceutical University and the Analytical Center under the Government of the Russian Federation.

It is expensive drugs (over 50,000 rubles) that increasingly determine the structure of public procurement. Over five years, their share of the total volume increased by 16.3 percentage points and reached 48.1% in 2025. Foreign companies dominate this segment, accounting for 65.8% of all supplies of such drugs through government procurement. Seven international companies, including Roche, Novartis, and AstraZeneca, are among the top 10 largest suppliers.

However, according to the report, Russian manufacturers are gradually regaining this position. Their share of government procurement of drugs over 50,000 rubles increased by 10.3 percentage points over five years, reaching 24.5% by the end of 2025. For example, in the structure of anticancer drug procurement, where the most expensive therapies are concentrated, Biocad has already taken second place in terms of supply volume (52.6 billion rubles), behind only Roche (60.1 billion). Researchers call this "a transformation of import substitution—from generics to biosimilars and proprietary molecules."

Experts interviewed by Kommersant noted the potential for further growth but also warned of systemic limitations. Since 2022, many international companies have suspended new clinical trials in Russia, which is slowing the registration of innovations.

The Inpharma Association believes that international pharmaceutical manufacturers have the resources to invest in innovations, which typically take decades to pay off. In addition to significant investment and a lengthy research cycle, developing an original drug entails a high level of scientific and commercial risks, added Alexander Bykov, Director of Healthcare Economics at R-Pharm. Moreover, he noted that the Russian market alone is generally insufficient to recoup these investments.

22/07/2026

Russian imports are prepared for 2025 to 2025 составила 54.1%, сократившись на 2.1 p. к предыдущему году, следует из подсчетов Санкт-Петербургского state-of-the-art chemical-pharmaceutical laboratory (СПХФУ) and Analytical center via правительстве РФ. С ними ознакомился «Ъ. Здоровье+». The natural weight loss is 0.8 p. p., do 35.4%.

This is not a new trend: imported preparatory material Please note that this is the minimum possible last week, следует из подсчетов. Trends in the state of “mass tabny” imports of cards средне- и низкоценовых сегментах”, говорится в documents. And it was possible to find out what was happening to Jeannerikov. Preferential treatment in Russia, analysis analysis.

There are no costs for import preparations and deposits превышает долю отечественных. Please note that the vehicle is being viewed by the “high contact” important automotive and segment innovation — там, где new technology and big investment. рынка — sвыше 1 трлн руб. заболевания пищеварительного тракта and противоопухолевые. The dominion is a multi-national government. в исследовании.

In terms of timing, it is necessary to provide the necessary parts for the vehicle. Preparation by local authorities. This is 50 тыс. руб., в 2025 году пришлось 65.8% for imported goods госторгах. It is 21.3 pcs. п. больше, чем в 2020 году. This is a natural transformation of this segment by the following: Negotiable 1.5% of import shipping.

The vehicle is left behind and the structure is visible. State: in 2025 it was assumed that 48.1% would be taken into account. пять лет 16.3 п. п. This is where people come from. Highly prepared, take a little time to prepare. Please note that the natural weight loss is 0.3 feet. п., до 0.5%, in this period.